title: [Efalizumab-induced pancytopenia].
authors.forename: A
authors.initials: A
authors.lastname: Nosbaum
authors.forename: C
authors.initials: C
authors.lastname: Allombert-Blaise
authors.forename: A
authors.initials: A
authors.lastname: Ly
authors.forename: D
authors.initials: D
authors.lastname: Jullien
authors.forename: M
authors.initials: M
authors.lastname: Faure
authors.forename: A
authors.initials: A
authors.lastname: Claudy
authors.forename: M
authors.initials: M
authors.lastname: Simon
mesh_terms: D000911:Antibodies, Monoclonal / Q000633:toxicity*; D061067:Antibodies, Monoclonal, Humanized; D001706:Biopsy; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010198:Pancytopenia / Q000139:chemically induced* / Q000473:pathology; D013736:Testicular Neoplasms / Q000188:drug therapy
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C472181:efalizumab